We are currently importing the latest prescribing data. You may see incomplete data across the site. Please check back in a couple of hours!

VMP 41872511000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Cabergoline 500microgram tablets
BNF code 0607010C0AAAAAA
Virtual Therapeutic Moiety Cabergoline
Date identifier became valid 26 May 2023
Previous product identifier 326064008
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Cabergoline
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 500.000
Strength value numerator unit microgram
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Cabergoline 500microgram tablets (A A H Pharmaceuticals Ltd)
Cabergoline 500microgram tablets (Accord-UK Ltd)
Cabergoline 500microgram tablets (Alliance Healthcare (Distribution) Ltd)
Cabergoline 500microgram tablets (CST Pharma Ltd)
Cabergoline 500microgram tablets (Medihealth (Northern) Ltd)
Cabergoline 500microgram tablets (Necessity Supplies Ltd)
Cabergoline 500microgram tablets (Sigma Pharmaceuticals Plc)
Cabergoline 500microgram tablets (Teva UK Ltd)
Dostinex 500microgram tablets (CST Pharma Ltd)
Dostinex 500microgram tablets (Lexon (UK) Ltd)
Dostinex 500microgram tablets (Necessity Supplies Ltd)
Dostinex 500microgram tablets (Pfizer Ltd)
Dostinex 500microgram tablets (Pilsco Ltd)
Virtual Medicinal Product Packs
Cabergoline 500microgram tablets 8 tablet

dm+d data retrieved from TRUD: release NHSBSA_6.2.0_20240617000001, imported on 17th June 2024 at 05:00:28.

Feedback